|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 447-455, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DK Cooper, PA Human, AG Rose, J Rees, M Keraan, B Reichart, E Du Toit and R Oriol
The role of ABO blood group compatibility on graft survival when
transplantation is performed between closely related animal species is
uncertain. Heart transplants (in the neck) were performed between donor
vervet monkeys and recipient baboons; no immunosuppressive therapy was
given. Survival in ABO-compatible pairs (group 1, n = 9) was for a mean of
10.3 (+/- 5.2) days, which was not significantly different from that in
ABO-incompatible pairs (group 2, n = 9: mean survival 7.3 +/- 5.6 days). In
group 2, however, three hearts were rejected hyperacutely within 60
minutes, whereas in group 1 only one heart was rejected within 24 hours
(not significant). Preformed anti-vervet monkey antibody was present in
only one of 18 baboons, but developed in eight others. ABO-specific
antibodies were present in all nine group 2 baboons and increased in titer
in six cases. Histopathologic features of vascular (humoral) rejection,
sometimes associated with cellular infiltration, were seen in a majority of
hearts in both groups. Though the number of animals in this study was
small, ABO-incompatibility would not appear to be a major factor in cardiac
xenograft survival when transplantation is performed between closely
related primate species, though early hyperacute rejection would seem more
likely to occur when blood group incompatibility is present.
ARTICLES
The role of ABO blood group compatibility in heart transplantation between closely related animal species. An experimental study using the vervet monkey to baboon cardiac xenograft model
Department of Cardiothoracic Surgery, University of Cape Town Medical School, Republic of South Africa.
This article has been cited by other articles:
![]() |
D. H. Adams, R. H. Chen, and A. Kadner Cardiac xenotransplantation: clinical experience and future direction Ann. Thorac. Surg., July 1, 2000; 70(1): 320 - 326. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |